Eli
Eli Lilly to acquire three small vaccine developers
Andrew covers the biopharmaceutical industry, scientific research and public health across the continent. You can reach Andrew confidentially on Signal at drawqjoseph.71. Eli Lilly announced Tuesday that it would buy three early- and mid-stage vaccine developers, giving the field a boost. The deals — which together could cost nearly $4 billion — are the latest […]
2 mins read
Sarepta, Eli Lilly, SSRI, NIH, Bristol effects
Do you want to stay at the top of science and politics to conduct biotechnology today? Register to get our Biotech newsletter in your reception box. Morning. Today, we are discussing how Duchenne patients and their families react to the shelves of Sarepta Therapeutics gene therapy, see a panel of the FDA composed largely of […]
2 mins read